{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:57:43Z","timestamp":1740135463722,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1121-4","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T13:07:11Z","timestamp":1560776831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Arrhythmic episodes in patients implanted with a cardioverter-defibrillator \u2013 results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P)"],"prefix":"10.1186","volume":"19","author":[{"name":"4P Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5936-4656","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Regoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beat","family":"Schaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firat","family":"Duru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza Mangoni di S.","family":"Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Naegli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haran","family":"Burri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Zbinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazmi","family":"Krasniqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Fromer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"key":"1121_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/europace\/euv411","volume":"18","author":"BL Wilkoff","year":"2016","unstructured":"Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, et al. 2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace. 2016;18:159\u201383.","journal-title":"Europace"},{"key":"1121_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225\u201337.","journal-title":"N Engl J Med"},{"key":"1121_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jacc.2006.03.037","volume":"48","author":"BL Wilkoff","year":"2006","unstructured":"Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM, et al. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006;48:330\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1121_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1540-8167.2010.01918.x","volume":"22","author":"KJ Volosin","year":"2011","unstructured":"Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling. J Cardiovasc Electrophysiol. 2011;22:280\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1121_CR5","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1540-8159.2004.00622.x","volume":"27","author":"MO Sweeney","year":"2004","unstructured":"Sweeney MO. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2004;27:1292\u2013305.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1121_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.86.2.363","volume":"86","author":"M Fromer","year":"1992","unstructured":"Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral J, et al. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Circulation. 1992;86:363\u201374.","journal-title":"Circulation"},{"key":"1121_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/jce.13170","volume":"28","author":"SA Strickberger","year":"2017","unstructured":"Strickberger SA, Canby R, Cooper J, Coppess M, Doshi R, John R, et al. Association of Antitachycardia pacing or shocks with survival in 69,000 patients with an implantable defibrillator. J Cardiovasc Electrophysiol. 2017;28:416\u201322.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1121_CR8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4037\/ajcc2006.15.4.389","volume":"15","author":"SA Thomas","year":"2006","unstructured":"Thomas SA, Friedmann E, Kao CW, Inguito P, Metcalf M, Kelley FJ, et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care. 2006;15:389\u201398.","journal-title":"Am J Crit Care"},{"key":"1121_CR9","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.jacc.2009.07.039","volume":"54","author":"JD Mishkin","year":"2009","unstructured":"Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, et al. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. J Am Coll Cardiol. 2009;54:1993\u20132000.","journal-title":"J Am Coll Cardiol"},{"key":"1121_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"AE Epstein","year":"2008","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (writing committee to revise the ACC\/AHA\/NASPE 2002 guideline update for implantation of cardiac pacemakers and Antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"1121_CR11","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1161\/01.CIR.0000145610.64014.E4","volume":"110","author":"MS Wathen","year":"2004","unstructured":"Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation. 2004;110:2591\u20136.","journal-title":"Circulation"},{"key":"1121_CR12","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/europace\/euv393","volume":"18","author":"A Fontenla","year":"2016","unstructured":"Fontenla A, Martinez-Ferrer JB, Alzueta J, Vinolas X, Garcia-Alberola A, Brugada J, et al. Incidence of arrhythmias in a large cohort of patients with current implantable cardioverter-defibrillators in Spain: results from the UMBRELLA registry. Europace. 2016;18:1726\u201334.","journal-title":"Europace"},{"key":"1121_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.hrthm.2015.01.017","volume":"12","author":"A Auricchio","year":"2015","unstructured":"Auricchio A, Schloss EJ, Kurita T, Meijer A, Gerritse B, Zweibel S, et al. Low inappropriate shock rates in patients with single- and dual\/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm. 2015;12:926\u201336.","journal-title":"Heart Rhythm"},{"key":"1121_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jacc.2008.05.011","volume":"52","author":"BL Wilkoff","year":"2008","unstructured":"Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (primary prevention parameters evaluation) study. J Am Coll Cardiol. 2008;52:541\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"1121_CR15","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1111\/j.1540-8167.2006.00643.x","volume":"17","author":"GJ Klein","year":"2006","unstructured":"Klein GJ, Gillberg JM, Tang A, Inbar S, Sharma A, Unterberg-Buchwald C, et al. Improving SVT discrimination in single-chamber ICDs: a new electrogram morphology-based algorithm. J Cardiovasc Electrophysiol. 2006;17:1310\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1121_CR16","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.2013.4598","volume":"309","author":"M Gasparini","year":"2013","unstructured":"Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB, et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA. 2013;309:1903\u201311.","journal-title":"JAMA"},{"key":"1121_CR17","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/europace\/euw032","volume":"18","author":"A Arenal","year":"2016","unstructured":"Arenal A, Proclemer A, Kloppe A, Lunati M, Martinez Ferrer JB, Hersi A, et al. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace. 2016;18:1719\u201325.","journal-title":"Europace"},{"key":"1121_CR18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.amjcard.2005.11.048","volume":"97","author":"JJ Germano","year":"2006","unstructured":"Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006;97:1255\u201361.","journal-title":"Am J Cardiol"},{"key":"1121_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jama.2014.4783","volume":"312","author":"A Proclemer","year":"2014","unstructured":"Proclemer A, Arenal A, Lunati M, Ferrer JB, Hersi A, Manotta L, et al. Association of long vs standard detection intervals for implantable cardioverter-defibrillators with hospitalizations and costs. JAMA. 2014;312:555\u20137.","journal-title":"JAMA"},{"key":"1121_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-018-0778-9","volume":"17","author":"C Sardu","year":"2018","unstructured":"Sardu C, Paolisso P, Sacra C, Santamaria M, de Lucia C, Ruocco A, et al. Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate. Cardiovasc Diabetol. 2018;17:137.","journal-title":"Cardiovasc Diabetol"},{"key":"1121_CR21","doi-asserted-by":"publisher","first-page":"e6558","DOI":"10.1097\/MD.0000000000006558","volume":"96","author":"C Sardu","year":"2017","unstructured":"Sardu C, Santamaria M, Funaro S, Sacra C, Barbieri M, Paolisso P, et al. Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome. Medicine (Baltimore). 2017;96:e6558.","journal-title":"Medicine (Baltimore)"},{"key":"1121_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ijcard.2016.11.094","volume":"227","author":"MG Kiuchi","year":"2017","unstructured":"Kiuchi MG, Chen S, P\u00fcrerfellner H. Incidence of ventricular arrhythmic events in CKD patients with ICD. Int J Cardiol. 2017;227:312\u20137.","journal-title":"Int J Cardiol"},{"key":"1121_CR23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fphys.2018.00758","volume":"9","author":"C Sardu","year":"2018","unstructured":"Sardu C, Marfella R, Santamaria M, Papini S, Parisi Q, et al. Stretch, injury and inflammation markers evaluation to predict clinical outcomes after implantable cardioverter defibrillator therapy in heart failure patients with metabolic syndrome. Front Physiol. 2018;9:758.","journal-title":"Front Physiol"},{"key":"1121_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10840-017-0297-8","volume":"50","author":"D Hofer","year":"2017","unstructured":"Hofer D, Steffel J, Hurlimann D, Haegeli L, Luscher TF, Duru F, et al. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice-an underestimated complication? J Interv Card Electrophysiol. 2017;50:219\u201326.","journal-title":"J Interv Card Electrophysiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1121-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1121-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1121-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T23:12:26Z","timestamp":1592262746000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1121-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1121-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"31 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical Review Board approval was obtained prior to study start from the corresponding institutions of all participating centers (Ethical Board of Tessin reference number: CE 2539). Every patient gave their written informed consent for participation in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Fran\u00e7ois Regoli declares speaker and consultation fees from Bayer, Boston Scientific, Microport, Medtronic, and is associate editor for BMC Cardiovascular Disorders. Dr. Beat Schaer discloses speaker\u2019s bureau fees from Medtronic and Microport. Dr. Peter Ammann is a European advisory board member for Medtronic. Lorenza Mangoni di S. Stefano is an employee of Medtronic Core Clinical Solutions. Dr. Martin Fromer is a consultant for Medtronic, Switzerland. Doctors Denis Graf, Firat Duru, Barbara Naegli, Haran Burri, Rainer Zbinden, Nazmi Krasniqi have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}